Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,649 | -95,591 | -64,858 | -32,940 | -116,271 |
| Depreciation Amortization | -3,608 | -2,621 | -1,479 | -541 | 1,286 |
| Other Working Capital | -3,704 | -554 | -1,613 | 357 | 6,369 |
| Other Operating Activity | 19,918 | 16,088 | 10,807 | 5,404 | 19,582 |
| Operating Cash Flow | $-100,043 | $-82,678 | $-57,143 | $-27,720 | $-89,034 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -154,719 | -135,565 | -106,246 | -33,097 | -176,528 |
| PPE Investments | N/A | N/A | N/A | -9 | -2,719 |
| Sale Of Investment | 264,588 | 222,734 | 150,782 | 88,526 | 172,417 |
| Investing Cash Flow | $109,869 | $87,169 | $44,536 | $55,420 | $-6,830 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,325 | 1,325 | 1,268 | 17 | 1,566 |
| Other Financing Activity | -9,133 | -9,133 | -9,133 | -9,133 | -406 |
| Financing Cash Flow | $-7,808 | $-7,808 | $-7,865 | $-9,116 | $1,160 |
| Exchange Rate Effect | -6 | -7 | -7 | N/A | 1 |
| Beginning Cash Position | 55,357 | 55,357 | 55,357 | 55,357 | 150,060 |
| End Cash Position | 57,369 | 52,033 | 34,878 | 73,941 | 55,357 |
| Net Cash Flow | $2,012 | $-3,324 | $-20,479 | $18,584 | $-94,703 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,043 | -82,678 | -57,143 | -27,720 | -89,034 |
| Capital Expenditure | N/A | 0 | 0 | -9 | -2,719 |
| Free Cash Flow | -100,043 | -82,678 | -57,143 | -27,729 | -91,753 |